Back to search

Article

Disease-modifying therapies for T1 hypointense lesions (Black Holes) volume in patients with multiple sclerosis: Protocol for a systematic review and meta-analysis

2021-06-27

Abstract excerpt

<h4>Rationale</h4> A major part of diagnosis and follow-up in patients with multiple sclerosis is based on MRI evaluations. As T1-hypointense lesions represent neural destruction or axonal loss and anticipate irreversible disability in the patients, evaluation of the effects of Disease-modifying therapies (DMTs) on the volume of black holes seems necessary. <h4>Objectives</h4> To evaluate the effects of FDA approv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
62feb3df-9458-56f5-b8c3-28ef3da400d3
DOI
10.1101/2021.06.25.21259388
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Disease-modifying therapies for T1 hypointense lesions (Black Holes) volume in patients with multiple sclerosis: Protocol for a systematic review and meta-analysisDOI 10.1101/2021.06.25.21259388
Select a neighboring publication to make it the new centre.